Scholars@Duke
Journal cover image

High-dose intravenous methylprednisolone for Kasabach-Merritt syndrome.

Publication ,  Journal Article
Ozsoylu, S
Published in: Am J Hematol
July 1989
Published version (DOI) Link to item

Duke Scholars

Thomas Lee Ortel
Author Thomas Lee Ortel Medicine, Hematology

Published In

Am J Hematol

DOI

10.1002/ajh.2830310316

ISSN

0361-8609

Publication Date

July 1989

Volume

31

Issue

3

Start / End Page

219 / 220

Location

United States

Related Subject Headings

  • Thrombocytopenia
  • Syndrome
  • Methylprednisolone
  • Injections, Intravenous
  • Infant
  • Immunology
  • Humans
  • Hemangioma
  • Female
  • Drug Administration Schedule
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ozsoylu, S. (1989). High-dose intravenous methylprednisolone for Kasabach-Merritt syndrome. Am J Hematol, 31(3), 219–220. https://doi.org/10.1002/ajh.2830310316
Ozsoylu, S. “High-dose intravenous methylprednisolone for Kasabach-Merritt syndrome.” Am J Hematol 31, no. 3 (July 1989): 219–20. https://doi.org/10.1002/ajh.2830310316.
Ozsoylu S. High-dose intravenous methylprednisolone for Kasabach-Merritt syndrome. Am J Hematol. 1989 Jul;31(3):219–20.
Ozsoylu, S. “High-dose intravenous methylprednisolone for Kasabach-Merritt syndrome.” Am J Hematol, vol. 31, no. 3, July 1989, pp. 219–20. Pubmed, doi:10.1002/ajh.2830310316.
Ozsoylu S. High-dose intravenous methylprednisolone for Kasabach-Merritt syndrome. Am J Hematol. 1989 Jul;31(3):219–220.
Journal cover image

Published In

Am J Hematol

DOI

10.1002/ajh.2830310316

ISSN

0361-8609

Publication Date

July 1989

Volume

31

Issue

3

Start / End Page

219 / 220

Location

United States

Related Subject Headings

  • Thrombocytopenia
  • Syndrome
  • Methylprednisolone
  • Injections, Intravenous
  • Infant
  • Immunology
  • Humans
  • Hemangioma
  • Female
  • Drug Administration Schedule